Management of head and neck squamous cell carcinoma in combination with pulmonary embolism: An adverse event of combined anti–PD-1 and EGFR neoadjuvant immunotherapy
Abstract
• The occurrence of postoperative combined pulmonary embolism is associated with increased risk of cardiovascular accidents due to neoadjuvant therapy. • MDT is a fundamental safeguard in the face of severe postoperative complications exacerbated by aPD-1 and aEGFR-based neoadjuvant therapy.
Fields of Study & Subjects
Head and Neck Cancer Studies
Cancer Immunotherapy and Biomarkers
Nonmelanoma Skin Cancer Studies
Publication details
- Journal / source
- Asian Journal of Surgery
- Volume
- 49
- Issue
- 7
- Pages
- 4030–4032
- Publication date
- 29 January 2026
- Language
- EN